Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer
Clinical trial NCT03470350 · WITHDRAWN
Trial details
- NCT number
- NCT03470350
- Sponsor
- The Netherlands Cancer Institute
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-24
- Primary completion
- 2020-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.